KK POLA ORBIS HOLDINGS header image

KK POLA ORBIS HOLDINGS

4927

Equity

ISIN JP3855900001 / Valor 11993070

Tokyo Stock Exchange (2024-09-18)
JPY 1,447.50+0.49%

KK POLA ORBIS HOLDINGS
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

KK POLA ORBIS HOLDINGS is a Japanese company primarily engaged in the manufacture and sale of cosmetics and skincare products.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Decline

KK POLA ORBIS HOLDINGS reported revenue of JP¥41.9 billion for the second quarter of 2024, marking a 4.1% decrease from the same period in 2023. This decline in revenue was a significant factor affecting the company's overall financial performance for the quarter.

Net Income Drop

The net income for KK POLA ORBIS HOLDINGS in the second quarter of 2024 was JP¥3.75 billion, which represents a 20% decrease compared to the second quarter of 2023. This reduction in net income highlights the challenges the company faced during this period.

Profit Margin Reduction

KK POLA ORBIS HOLDINGS saw its profit margin decrease to 8.9% in the second quarter of 2024, down from 11% in the same quarter of the previous year. The lower revenue was a primary driver behind this reduction in profit margin.

Earnings Per Share (EPS)

The earnings per share (EPS) for KK POLA ORBIS HOLDINGS in the second quarter of 2024 was JP¥16.95, down from JP¥21.07 in the second quarter of 2023. Despite the decline, the EPS exceeded analyst estimates by 42%, indicating better-than-expected profitability on a per-share basis.

Future Revenue Forecast

Looking ahead, KK POLA ORBIS HOLDINGS's revenue is forecast to grow at an average annual rate of 3.8% over the next three years. This growth rate is slightly below the 4.0% forecast for the Personal Products industry in Japan, suggesting a modest outlook for the company's future revenue performance.

Summarized from source with an LLMView Source

Key figures

-19.8%1Y
-45.0%3Y
-41.2%5Y

Performance

24.5%1Y
27.2%3Y
29.4%5Y

Volatility

Market cap

2349 M

Market cap (USD)

Daily traded volume (Shares)

557,200

Daily traded volume (Shares)

1 day high/low

1450 / 1428.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%EUR 49.73
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.64%EUR 34.22
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%EUR 58.75
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%USD 114.31
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.46%USD 49.91
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 26.71
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 77.94
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 12.00
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Valor: 30132056
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%USD 35.63
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 46.23